Replies to post #214 on Fate Therapeutics Inc (FATE)

[jondoeuk]

Engineered iPSC-derived NK cells as next-generation immunotherapies for cancer https://www.abstractsonline.com/pp8/#!/10828/presentation/3035

A novel method for clinical scale production of natural killer cells from clonal master induced pluripotent stem cells with CISH knockout for next generation, off-the-shelf cancer immunotherapy https://www.abstractsonline.com/pp8/#!/10828/presentation/9400

Developing an allogeneic iPSC derived macrophage cell therapy for oncology https://www.abstractsonline.com/pp8/#!/10828/presentation/3344